![Minakem Generic APIs](https://www.pharmacompass.com/image/flap/minakem-header-desktop-w27gif-57924.gif)
![Minakem Generic APIs](https://www.pharmacompass.com/image/flap/minakem-header-mobile-w27gif-62411.gif)
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.prnewswire.com/news-releases/ionis-announces-olezarsen-fcs-new-drug-application-accepted-for-priority-review-and-enrollment-in-phase-3-shtg-program-completed-302181549.html
https://www.prnewswire.com/news-releases/ionis-announces-expanded-licensing-agreement-with-otsuka-in-asia-pacific-for-investigational-medicine-donidalorsen-in-hereditary-angioedema-302175393.html
https://www.prnewswire.com/news-releases/ionis-to-present-at-td-cowen-genetic-medicines--rna-summit-302174669.html
https://www.biopharmadive.com/news/gsk-acquire-elsie-oligonucleotides-rna-drug/718257/
https://www.prnewswire.com/news-releases/ionis-presents-positive-results-from-oasis-hae-and-oasisplus-studies-of-investigational-medicine-donidalorsen-in-patients-with-hereditary-angioedema-302160162.html
https://www.prnewswire.com/news-releases/ionis-to-hold-donidalorsen-phase-3-data-webcast-302156276.html
https://www.prnewswire.com/news-releases/new-data-from-the-phase-3-neuro-ttransform-study-evaluating-wainua-eplontersen-to-be-presented-at-the-2024-international-symposium-on-amyloidosis-isa-302150473.html
https://www.reuters.com/business/healthcare-pharmaceuticals/biogen-ionis-will-discontinue-development-their-als-drug-2024-05-16/
https://www.prnewswire.com/news-releases/ionis-and-biogen-announce-topline-phase-12-study-results-of-investigational-drug-in-amyotrophic-lateral-sclerosis-302147377.html
https://www.prnewswire.com/news-releases/ionis-announces-positive-topline-results-from-phase-12a-trial-of-ion582-for-angelman-syndrome-302147385.html